These were before discovered to be frequently associated to SSc with otherwise no SSc-specific antibodies (100), such as the recently discovered Anti-eIF2B (Eukaryotic initiation factor 2B) (101), which can be found in ANA-negative patients and has clinical associations with dcSSc and SSc-ILD (102). This evidence concerns the gene BTG3 and systemic sclerosis.